Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Biden cover-up probe heats up as another ex-White House aide sits down with GOP

by admin July 12, 2025
July 12, 2025
Biden cover-up probe heats up as another ex-White House aide sits down with GOP

A former top White House advisor is slated to appear before House Oversight Committee investigators on Friday as GOP lawmakers probe whether ex-President Joe Biden’s top aides covered up evidence of his mental and physical decline.

Ashley Williams, who served as deputy director of Oval Office Operations during the Biden administration, is expected to sit with investigators behind closed doors for a transcribed interview around 11 a.m. Friday.

If she appears, Williams will be the third member of the former president’s White House inner circle summoned in Comer’s probe in recent weeks.

In addition to whether senior aides covered up Biden’s alleged decline, Comer is looking at whether any presidential orders were signed via autopen without the former commander-in-chief’s knowledge.

Any allegations of wrongdoing so far have been denied by the ex-president’s allies.

But Republican investigators have pointed to Biden’s disastrous June 2024 debate and subsequent revelations in the media that there were more concerns from Biden’s inner circle about his fitness for office than previously known.

Williams was one of three then-Biden aides called before Comer’s House Oversight Committee in July 2024 to discuss the former president’s mental state, but the White House at the time called it a ‘baseless political stunt’ to NBC News.

Her expected appearance on Friday comes two days after ex-Biden White House physician Dr. Kevin O’Connor briefly sat down with investigators on Wednesday.

O’Connor’s encounter with the committee lasted roughly 30 minutes, with the doctor invoking the Fifth Amendment for all questions except his name.

‘It’s clear there was a conspiracy to cover up President Biden’s cognitive decline after Dr. Kevin O’Connor, Biden’s physician and family business associate, refused to answer any questions and chose to hide behind the Fifth Amendment,’ Comer said in a statement after O’Connor’s appearance.

‘Dr. O’Connor took the Fifth when asked if he was told to lie about President Biden’s health and whether he was fit to be President of the United States. Congress must assess legislative solutions to prevent such a cover up from happening again. We will continue to interview more Biden White House aides to get the answers Americans deserve.’

O’Connor’s lawyers said he did so out of concerns that House investigators would violate doctor-patient privilege.

‘This Committee has indicated to Dr. O’Connor and his attorneys that it does not intend to honor one of the most well-known privileges in our law – the physician patient privilege. Instead, the Committee has indicated that it will demand that Dr. O’Connor reveal, without any limitations, confidential information regarding his medical examinations, treatment, and care of President Biden,’ the attorney statement said.

‘Revealing confidential patient information would violate the most fundamental ethical duty of a physician, could result in revocation of Dr. O’Connor’s medical license, and would subject Dr. O’Connor to potential civil liability. Dr. O’Connor will not violate his oath of confidentiality to any of his patients, including President Biden.’

This post appeared first on FOX NEWS

previous post
JONATHAN TURLEY: Justice Jackson plays pundit to dismay of SCOTUS colleagues
next post
NorthStar Gaming Announces Grant of Equity Incentive Awards to Non-Executive Directors in Lieu of Cash Compensation

Related Posts

President Trump takes on ‘Big Pharma’ by signing...

May 13, 2025

Trump considers former defense attorney Emil Bove for...

May 20, 2025

Trump signs executive order to protect Americans from...

April 1, 2025

Trump shoots down rumors he will seek 3rd...

May 5, 2025

‘Mr. Brexit’ advocates for UK DOGE over ‘complete...

February 13, 2025

Alex Soros in hot seat after left-wing outlet...

April 27, 2025

Monica Crowley clears Senate confirmation for key State...

May 13, 2025

DOGE terminates billions in contracts, including $361K for...

April 30, 2025

Dem senator plows ahead with war powers resolution...

June 25, 2025

Vance says Russia’s demands are too high, but...

May 8, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved